{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:09:27Z","timestamp":1793462967236,"version":"4.5.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Biofilms Microbiomes"],"DOI":"10.1038\/s41522-024-00637-y","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T09:51:50Z","timestamp":1736329910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["DJK-5, an anti-biofilm peptide, increases Staphylococcus aureus sensitivity to colistin killing in co-biofilms with Pseudomonas aeruginosa"],"prefix":"10.1038","volume":"11","author":[{"given":"Samuel J. T.","family":"Wardell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4086-3869","authenticated-orcid":false,"given":"Deborah B. Y.","family":"Yung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupriya","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3621-3772","authenticated-orcid":false,"given":"Mihnea","family":"Bostina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg","family":"Overhage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5989-8503","authenticated-orcid":false,"given":"Robert E. W.","family":"Hancock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5750-7505","authenticated-orcid":false,"given":"Daniel","family":"Pletzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"key":"637_CR1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1089\/wound.2021.0026","volume":"10","author":"CK Sen","year":"2021","unstructured":"Sen, C. K. Human wound and its burden: updated 2020 compendium of estimates. Adv. Wound Care 10, 281\u2013292 (2021).","journal-title":"Adv. Wound Care"},{"key":"637_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jcma.2017.07.012","volume":"81","author":"M Jamal","year":"2018","unstructured":"Jamal, M. et al. Bacterial biofilm and associated infections. J. Chin. Med. Assoc. 81, 7\u201311 (2018).","journal-title":"J. Chin. Med. Assoc."},{"key":"637_CR3","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3201\/eid0809.020063","volume":"8","author":"RM Donlan","year":"2002","unstructured":"Donlan, R. M. Biofilms: microbial life on surfaces. Emerg. Infect. Dis. 8, 881\u2013890 (2002).","journal-title":"Emerg. Infect. Dis."},{"key":"637_CR4","doi-asserted-by":"publisher","unstructured":"Anju, V. T. et al. Polymicrobial infections and biofilms: clinical significance and eradication strategies. Antibiotics 11, https:\/\/doi.org\/10.3390\/antibiotics11121731 (2022)","DOI":"10.3390\/antibiotics11121731"},{"key":"637_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-390","volume":"14","author":"M Pammi","year":"2014","unstructured":"Pammi, M., Zhong, D., Johnson, Y., Revell, P. & Versalovic, J. Polymicrobial bloodstream infections in the neonatal intensive care unit are associated with increased mortality: a case-control study. BMC Infect. Dis. 14, 390 (2014).","journal-title":"BMC Infect. Dis."},{"key":"637_CR6","doi-asserted-by":"publisher","first-page":"e1005258","DOI":"10.1371\/journal.ppat.1005258","volume":"11","author":"LM Filkins","year":"2015","unstructured":"Filkins, L. M. & O\u2019Toole, G. A. Cystic fibrosis lung infections: polymicrobial, complex, and hard to treat. PLoS Pathog. 11, e1005258 (2015).","journal-title":"PLoS Pathog."},{"key":"637_CR7","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1016\/j.jmb.2016.05.006","volume":"428","author":"WH Tay","year":"2016","unstructured":"Tay, W. H., Chong, K. K. & Kline, K. A. Polymicrobial-Host Interactions during Infection. J. Mol. Biol. 428, 3355\u20133371 (2016).","journal-title":"J. Mol. Biol."},{"key":"637_CR8","doi-asserted-by":"publisher","first-page":"4718","DOI":"10.1128\/IAI.02198-14","volume":"82","author":"S DeLeon","year":"2014","unstructured":"DeLeon, S. et al. Synergistic interactions of Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro wound model. Infect. Immun. 82, 4718\u20134728 (2014).","journal-title":"Infect. Immun."},{"key":"637_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3389\/fcimb.2017.00125","volume":"7","author":"MK Yadav","year":"2017","unstructured":"Yadav, M. K., Chae, S. W., Go, Y. Y., Im, G. J. & Song, J. J. In vitro multi-species biofilms of methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa and their host interaction during in vivo colonization of an otitis media rat model. Front Cell Infect. Microbiol 7, 125 (2017).","journal-title":"Front Cell Infect. Microbiol"},{"key":"637_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-52975-z","volume":"9","author":"P Briaud","year":"2019","unstructured":"Briaud, P. et al. Coexistence with Pseudomonas aeruginosa alters Staphylococcus aureus transcriptome, antibiotic resistance and internalization into epithelial cells. Sci. Rep. 9, 16564 (2019).","journal-title":"Sci. Rep."},{"key":"637_CR11","first-page":"365","volume":"89","author":"V Tzaneva","year":"2016","unstructured":"Tzaneva, V., Mladenova, I., Todorova, G. & Petkov, D. Antibiotic treatment and resistance in chronic wounds of vascular origin. Clujul Med. 89, 365 (2016).","journal-title":"Clujul Med."},{"key":"637_CR12","doi-asserted-by":"publisher","unstructured":"Manos, J. Current and emerging therapies to combat cystic fibrosis lung infections. Microorganisms 9, https:\/\/doi.org\/10.3390\/microorganisms9091874 (2021)","DOI":"10.3390\/microorganisms9091874"},{"key":"637_CR13","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.2217\/fmb-2021-0150","volume":"16","author":"JS Elborn","year":"2021","unstructured":"Elborn, J. S., Flume, P. A., Van Devanter, D. R. & Procaccianti, C. Management of chronic Pseudomonas aeruginosa infection with inhaled levofloxacin in people with cystic fibrosis. Future Microbiol. 16, 1087\u20131104 (2021).","journal-title":"Future Microbiol."},{"key":"637_CR14","doi-asserted-by":"publisher","unstructured":"Li, D. & Schneider-Futschik, E. K. Current and emerging inhaled antibiotics for chronic pulmonary Pseudomonas aeruginosa and Staphylococcus aureus infections in cystic fibrosis. Antibiotics 12, https:\/\/doi.org\/10.3390\/antibiotics12030484 (2023)","DOI":"10.3390\/antibiotics12030484"},{"key":"637_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1164\/rccm.201105-0924OC","volume":"185","author":"BC Trapnell","year":"2012","unstructured":"Trapnell, B. C. et al. Fosfomycin\/tobramycin for inhalation in patients with cystic fibrosis with Pseudomonas airway infection. Am. J. Respir. Crit. Care Med 185, 171\u2013178 (2012).","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"637_CR16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jcf.2018.07.005","volume":"18","author":"R Dezube","year":"2019","unstructured":"Dezube, R. et al. Eradication of persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis. J. Cyst. Fibros. 18, 357\u2013363 (2019).","journal-title":"J. Cyst. Fibros."},{"key":"637_CR17","first-page":"38","volume":"22","author":"A Farajzadeh Sheikh","year":"2019","unstructured":"Farajzadeh Sheikh, A. et al. Molecular epidemiology of colistin-resistant Pseudomonas aeruginosa producing NDM-1 from hospitalized patients in Iran. Iran. J. Basic Med. Sci. 22, 38\u201342 (2019).","journal-title":"Iran. J. Basic Med. Sci."},{"key":"637_CR18","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s12866-021-02388-8","volume":"21","author":"DA Torres","year":"2021","unstructured":"Torres, D. A. et al. Colistin resistance in Gram-negative bacteria analysed by five phenotypic assays and inference of the underlying genomic mechanisms. BMC Microbiol 21, 321 (2021).","journal-title":"BMC Microbiol"},{"key":"637_CR19","first-page":"47","volume":"9","author":"A Gonzalez-Ruiz","year":"2016","unstructured":"Gonzalez-Ruiz, A., Seaton, R. A. & Hamed, K. Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections. Infect. Drug Resist. 9, 47\u201358 (2016).","journal-title":"Infect. Drug Resist."},{"key":"637_CR20","doi-asserted-by":"publisher","unstructured":"Andrade, F. F., Silva, D., Rodrigues, A. & Pina-Vaz, C. Colistin update on its mechanism of action and resistance, present and future challenges. Microorganisms 8, https:\/\/doi.org\/10.3390\/microorganisms8111716 (2020)","DOI":"10.3390\/microorganisms8111716"},{"key":"637_CR21","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1128\/AAC.44.12.3317-3321.2000","volume":"44","author":"L Zhang","year":"2000","unstructured":"Zhang, L., Dhillon, P., Yan, H., Farmer, S. & Hancock, R. E. Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44, 3317\u20133321 (2000).","journal-title":"Antimicrob. Agents Chemother."},{"key":"637_CR22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1473-3099(05)70051-7","volume":"5","author":"REW Hancock","year":"2005","unstructured":"Hancock, R. E. W. Mechanisms of action of newer antibiotics for Gram-positive pathogens. Lancet Infect. Dis. 5, 209\u2013218 (2005).","journal-title":"Lancet Infect. Dis."},{"key":"637_CR23","doi-asserted-by":"publisher","first-page":"6253","DOI":"10.1016\/j.bmc.2016.05.052","volume":"24","author":"SD Taylor","year":"2016","unstructured":"Taylor, S. D. & Palmer, M. The action mechanism of daptomycin. Bioorg. Med Chem. 24, 6253\u20136268 (2016).","journal-title":"Bioorg. Med Chem."},{"key":"637_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkx349","volume":"73","author":"M Heidary","year":"2018","unstructured":"Heidary, M. et al. Daptomycin. J. Antimicrob. Chemother. 73, 1\u201311 (2018).","journal-title":"J. Antimicrob. Chemother."},{"key":"637_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15257-1","volume":"11","author":"F Grein","year":"2020","unstructured":"Grein, F. et al. Ca(2+)-Daptomycin targets cell wall biosynthesis by forming a tripartite complex with undecaprenyl-coupled intermediates and membrane lipids. Nat. Commun. 11, 1455 (2020).","journal-title":"Nat. Commun."},{"key":"637_CR26","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1080\/22221751.2020.1754133","volume":"9","author":"MAE El-Sayed Ahmed","year":"2020","unstructured":"El-Sayed Ahmed, M. A. E. et al. Colistin and its role in the era of antibiotic resistance: an extended review (2000-2019). Emerg. Microbes Infect. 9, 868\u2013885 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"637_CR27","doi-asserted-by":"publisher","unstructured":"Yu, Z., Zhu, Y., Fu, J., Qiu, J. & Yin, J. Enhanced NADH metabolism involves colistin-induced killing of Bacillus subtilis and Paenibacillus polymyxa. Molecules 24, https:\/\/doi.org\/10.3390\/molecules24030387 (2019)","DOI":"10.3390\/molecules24030387"},{"key":"637_CR28","first-page":"3385","volume":"73","author":"H Rudilla","year":"2018","unstructured":"Rudilla, H. et al. Novel synthetic polymyxins kill Gram-positive bacteria. J. Antimicrob. Chemother. 73, 3385\u20133390 (2018).","journal-title":"J. Antimicrob. Chemother."},{"key":"637_CR29","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/978-3-030-16373-0_13","volume":"1145","author":"J Lora-Tamayo","year":"2019","unstructured":"Lora-Tamayo, J., Murillo, O. & Ariza, J. Clinical use of colistin in biofilm-associated infections. Adv. Exp. Med Biol. 1145, 181\u2013195 (2019).","journal-title":"Adv. Exp. Med Biol."},{"key":"637_CR30","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.chembiol.2015.01.002","volume":"22","author":"C de la Fuente-N\u00fa\u00f1ez","year":"2015","unstructured":"de la Fuente-N\u00fa\u00f1ez, C. et al. D-enantiomeric peptides that eradicate wild-type and multidrug-resistant biofilms and protect against lethal Pseudomonas aeruginosa infections. Chem. Biol. 22, 196\u2013205 (2015).","journal-title":"Chem. Biol."},{"key":"637_CR31","doi-asserted-by":"publisher","first-page":"33519","DOI":"10.1073\/pnas.2007626117","volume":"117","author":"CR Belanger","year":"2020","unstructured":"Belanger, C. R. et al. Identification of novel targets of azithromycin activity against Pseudomonas aeruginosa grown in physiologically relevant media. Proc. Natl Acad. Sci. USA 117, 33519\u201333529 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"637_CR32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ebiom.2016.09.015","volume":"12","author":"SC Mansour","year":"2016","unstructured":"Mansour, S. C. et al. Bacterial abscess formation is controlled by the stringent stress response and can be targeted therapeutically. EBioMedicine 12, 219\u2013226 (2016).","journal-title":"EBioMedicine"},{"key":"637_CR33","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.3389\/fmicb.2017.01867","volume":"8","author":"D Pletzer","year":"2017","unstructured":"Pletzer, D., Wolfmeier, H., Bains, M. & Hancock, R. E. W. Synthetic peptides to target stringent response-controlled virulence in a Pseudomonas aeruginosa Murine Cutaneous Infection Model. Front Microbiol 8, 1867 (2017).","journal-title":"Front Microbiol"},{"key":"637_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2021.111697","volume":"202","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Covalent immobilization of DJK-5 peptide on porous titanium for enhanced antibacterial effects and restrained inflammatory osteoclastogenesis. Colloids Surf. B Biointerfaces 202, 111697 (2021).","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"637_CR35","doi-asserted-by":"publisher","first-page":"e1007084","DOI":"10.1371\/journal.ppat.1007084","volume":"14","author":"D Pletzer","year":"2018","unstructured":"Pletzer, D., Mansour, S. C. & Hancock, R. E. W. Synergy between conventional antibiotics and anti-biofilm peptides in a murine, sub-cutaneous abscess model caused by recalcitrant ESKAPE pathogens. PLoS Pathog. 14, e1007084 (2018).","journal-title":"PLoS Pathog."},{"key":"637_CR36","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.tim.2013.01.002","volume":"21","author":"CC Boutte","year":"2013","unstructured":"Boutte, C. C. & Crosson, S. Bacterial lifestyle shapes stringent response activation. Trends Microbiol. 21, 174\u2013180 (2013).","journal-title":"Trends Microbiol."},{"key":"637_CR37","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.freeradbiomed.2020.10.322","volume":"161","author":"VN Fritsch","year":"2020","unstructured":"Fritsch, V. N. et al. The alarmone (p)ppGpp confers tolerance to oxidative stress during the stationary phase by maintenance of redox and iron homeostasis in Staphylococcus aureus. Free Radic. Biol. Med. 161, 351\u2013364 (2020).","journal-title":"Free Radic. Biol. Med."},{"key":"637_CR38","doi-asserted-by":"publisher","unstructured":"Orazi, G. & O\u2019Toole, G. A. Pseudomonas aeruginosa alters Staphylococcus aureus sensitivity to vancomycin in a biofilm model of cystic fibrosis infection. mBio 8, https:\/\/doi.org\/10.1128\/mBio.00873-17 (2017)","DOI":"10.1128\/mBio.00873-17"},{"key":"637_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-017-0035-0","volume":"3","author":"T Beaudoin","year":"2017","unstructured":"Beaudoin, T. et al. Staphylococcus aureus interaction with Pseudomonas aeruginosa biofilm enhances tobramycin resistance. NPJ Biofilms Microbiomes 3, 25 (2017).","journal-title":"NPJ Biofilms Microbiomes"},{"key":"637_CR40","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/14787210.2018.1417036","volume":"16","author":"JL Del Pozo","year":"2018","unstructured":"Del Pozo, J. L. Biofilm-related disease. Expert Rev. Anti Infect. Ther. 16, 51\u201365 (2018).","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"637_CR41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.mib.2017.09.007","volume":"42","author":"L Radlinski","year":"2018","unstructured":"Radlinski, L. & Conlon, B. P. Antibiotic efficacy in the complex infection environment. Curr. Opin. Microbiol 42, 19\u201324 (2018).","journal-title":"Curr. Opin. Microbiol"},{"key":"637_CR42","doi-asserted-by":"publisher","unstructured":"Belanger, C. R. et al. Identification of novel targets of azithromycin activity against Pseudomonas aeruginosa grown in physiologically relevant media. Proc. Natl Acad. Sci., 202007626. https:\/\/doi.org\/10.1073\/pnas.2007626117 (2020)","DOI":"10.1073\/pnas.2007626117"},{"key":"637_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-020-00182-4","volume":"7","author":"B Wu","year":"2021","unstructured":"Wu, B. et al. Human organoid biofilm model for assessing antibiofilm activity of novel agents. NPJ Biofilms Microbiomes 7, 8 (2021).","journal-title":"NPJ Biofilms Microbiomes"},{"key":"637_CR44","doi-asserted-by":"crossref","unstructured":"Camus, L., Briaud, P., Vandenesch, F., Dol\u00e9ans-Jordheim, A. & Moreau, K. In Pseudomonas aeruginosa: Biology, Pathogenesis and Control Strategies (eds Filloux, A. & Ramos, J.-L.) 397-424 (Springer International Publishing, 2022).","DOI":"10.1007\/978-3-031-08491-1_15"},{"key":"637_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/mmi.14699","volume":"116","author":"DBY Yung","year":"2021","unstructured":"Yung, D. B. Y., Sircombe, K. J. & Pletzer, D. Friends or enemies? The complicated relationship between Pseudomonas aeruginosa and Staphylococcus aureus. Mol. Microbiol 116, 1\u201315 (2021).","journal-title":"Mol. Microbiol"},{"key":"637_CR46","doi-asserted-by":"publisher","unstructured":"Orazi, G., Ruoff, K. L. & O\u2019Toole, G. A. Pseudomonas aeruginosa Increases the Sensitivity of Biofilm-Grown Staphylococcus aureus to Membrane-Targeting Antiseptics and Antibiotics. mBio 10, https:\/\/doi.org\/10.1128\/mBio.01501-19 (2019)","DOI":"10.1128\/mBio.01501-19"},{"key":"637_CR47","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1080\/1040841X.2019.1700209","volume":"45","author":"AP Magalhaes","year":"2019","unstructured":"Magalhaes, A. P., Jorge, P. & Pereira, M. O. Pseudomonas aeruginosa and Staphylococcus aureus communication in biofilm infections: insights through network and database construction. Crit. Rev. Microbiol 45, 712\u2013728 (2019).","journal-title":"Crit. Rev. Microbiol"},{"key":"637_CR48","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1128\/JB.00059-15","volume":"197","author":"LM Filkins","year":"2015","unstructured":"Filkins, L. M. et al. Coculture of Staphylococcus aureus with Pseudomonas aeruginosa Drives S. aureus towards Fermentative Metabolism and Reduced Viability in a Cystic Fibrosis Model. J. Bacteriol. 197, 2252\u20132264 (2015).","journal-title":"J. Bacteriol."},{"key":"637_CR49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/978-1-0716-1550-8_6","volume":"2341","author":"CN Krute","year":"2021","unstructured":"Krute, C. N., Seawell, N. A. & Bose, J. L. Measuring Staphylococcal promoter activities using a codon-optimized beta-Galactosidase Reporter. Methods Mol. Biol. 2341, 37\u201344 (2021).","journal-title":"Methods Mol. Biol."},{"key":"637_CR50","doi-asserted-by":"publisher","unstructured":"Krute, C. N., Rice, K. C. & Bose, J. L. VfrB Is a Key Activator of the Staphylococcus aureus SaeRS Two-Component System. J. Bacteriol. 199, https:\/\/doi.org\/10.1128\/JB.00828-16 (2017)","DOI":"10.1128\/JB.00828-16"},{"key":"637_CR51","doi-asserted-by":"publisher","first-page":"e00140","DOI":"10.1128\/mBio.00140-17","volume":"8","author":"D Pletzer","year":"2017","unstructured":"Pletzer, D., Mansour, S. C., Wuerth, K., Rahanjam, N. & Hancock, R. E. W. New mouse model for chronic infections by Gram-negative bacteria enabling the study of anti-infective efficacy and host-microbe interactions. mBio 8, e00140\u201300117 (2017).","journal-title":"mBio"},{"key":"637_CR52","doi-asserted-by":"publisher","first-page":"e1008444","DOI":"10.1371\/journal.ppat.1008444","volume":"16","author":"D Pletzer","year":"2020","unstructured":"Pletzer, D. et al. Surfing motility is a complex adaptation dependent on the stringent stress response in Pseudomonas aeruginosa LESB58. PLoS Pathog. 16, e1008444 (2020).","journal-title":"PLoS Pathog."},{"key":"637_CR53","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.tim.2016.01.008","volume":"24","author":"C Winstanley","year":"2016","unstructured":"Winstanley, C., O\u2019Brien, S. & Brockhurst, M. A. Pseudomonas aeruginosa evolutionary adaptation and diversification in cystic fibrosis chronic lung infections. Trends Microbiol 24, 327\u2013337 (2016).","journal-title":"Trends Microbiol"},{"key":"637_CR54","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.3389\/fimmu.2018.02416","volume":"9","author":"E Faure","year":"2018","unstructured":"Faure, E., Kwong, K. & Nguyen, D. Pseudomonas aeruginosa in chronic lung infections: how to adapt within the host? Front Immunol. 9, 2416 (2018).","journal-title":"Front Immunol."},{"key":"637_CR55","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1128\/CMR.00013-11","volume":"25","author":"BM Peters","year":"2012","unstructured":"Peters, B. M., Jabra-Rizk, M. A., O\u2019May, G. A., Costerton, J. W. & Shirtliff, M. E. Polymicrobial interactions: impact on pathogenesis and human disease. Clin. Microbiol Rev. 25, 193\u2013213 (2012).","journal-title":"Clin. Microbiol Rev."},{"key":"637_CR56","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12223-023-01070-y","volume":"68","author":"A Kulshrestha","year":"2023","unstructured":"Kulshrestha, A. & Gupta, P. Combating polymicrobial biofilm: recent approaches. Folia Microbiol. 68, 495\u2013505 (2023).","journal-title":"Folia Microbiol."},{"key":"637_CR57","doi-asserted-by":"publisher","unstructured":"Poirier, S. & Jean-Pierre, F. Growing a cystic fibrosis-relevant polymicrobial biofilm to probe community phenotypes. bioRxiv, 2024.2001.2026.577445. https:\/\/doi.org\/10.1101\/2024.01.26.577445 (2024)","DOI":"10.1101\/2024.01.26.577445"},{"key":"637_CR58","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.drudis.2021.02.004","volume":"26","author":"C Bailly","year":"2021","unstructured":"Bailly, C. & Vergoten, G. A new horizon for the old antibacterial drug clofoctol. Drug Discov. Today 26, 1302\u20131310 (2021).","journal-title":"Drug Discov. Today"},{"key":"637_CR59","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.04275-22","volume":"11","author":"D Collalto","year":"2023","unstructured":"Collalto, D. et al. Synergistic activity of colistin in combination with clofoctol against colistin resistant Gram-Negative pathogens. Microbiol Spectr. 11, e0427522 (2023).","journal-title":"Microbiol Spectr."},{"key":"637_CR60","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.3389\/fmicb.2018.02805","volume":"9","author":"W Si","year":"2018","unstructured":"Si, W., Wang, L., Usongo, V. & Zhao, X. Colistin induces S. aureus susceptibility to bacitracin. Front Microbiol 9, 2805 (2018).","journal-title":"Front Microbiol"},{"key":"637_CR61","doi-asserted-by":"publisher","unstructured":"Choi, S. et al. Antagonistic effect of colistin on vancomycin activity against methicillin-resistant Staphylococcus aureus in in vitro and in vivo studies. Antimicrob. Agents Chemother. 64, https:\/\/doi.org\/10.1128\/aac.01925-19 (2020)","DOI":"10.1128\/aac.01925-19"},{"key":"637_CR62","doi-asserted-by":"publisher","unstructured":"Pulkkinen, K. et al. Effect of resource availability on evolution of virulence and competition in an environmentally transmitted pathogen. FEMS Microbiol. Ecol. 94 https:\/\/doi.org\/10.1093\/femsec\/fiy060 (2018)","DOI":"10.1093\/femsec\/fiy060"},{"key":"637_CR63","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ebiom.2017.05.026","volume":"20","author":"SC Ersoy","year":"2017","unstructured":"Ersoy, S. C. et al. Correcting a fundamental flaw in the paradigm for antimicrobial susceptibility testing. EBioMedicine 20, 173\u2013181 (2017).","journal-title":"EBioMedicine"},{"key":"637_CR64","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000491497","volume":"11","author":"M Dostert","year":"2019","unstructured":"Dostert, M., Belanger, C. R. & Hancock, R. E. W. Design and assessment of anti-biofilm peptides: steps toward clinical application. J. Innate Immun. 11, 193\u2013204 (2019).","journal-title":"J. Innate Immun."},{"key":"637_CR65","doi-asserted-by":"publisher","unstructured":"Ridyard, K. E. et al. Synergy between Human Peptide LL-37 and Polymyxin B against Planktonic and Biofilm Cells of Escherichia coli and Pseudomonas aeruginosa. Antibiotics 12, https:\/\/doi.org\/10.3390\/antibiotics12020389 (2023)","DOI":"10.3390\/antibiotics12020389"},{"key":"637_CR66","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.saa.2019.03.077","volume":"217","author":"A Poursoleiman","year":"2019","unstructured":"Poursoleiman, A. et al. Polymyxins interaction to the human serum albumin: a thermodynamic and computational study. Spectrochim. Acta A Mol. Biomol. Spectrosc. 217, 155\u2013163 (2019).","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"637_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-80540-6","volume":"11","author":"WH Tang","year":"2021","unstructured":"Tang, W. H., Wang, C. F. & Liao, Y. D. Fetal bovine serum albumin inhibits antimicrobial peptide activity and binds drug only in complex with \u03b11-antitrypsin. Sci. Rep. 11, 1267 (2021).","journal-title":"Sci. Rep."},{"key":"637_CR68","doi-asserted-by":"publisher","first-page":"e58277","DOI":"10.1371\/journal.pone.0058277","volume":"8","author":"MT Ferreira","year":"2013","unstructured":"Ferreira, M. T., Manso, A. S., Gaspar, P., Pinho, M. G. & Neves, A. R. Effect of oxygen on glucose metabolism: utilization of lactate in Staphylococcus aureus as revealed by in vivo NMR studies. PLoS One 8, e58277 (2013).","journal-title":"PLoS One"},{"key":"637_CR69","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1021\/jp409936v","volume":"118","author":"K Baler","year":"2014","unstructured":"Baler, K. et al. Electrostatic unfolding and interactions of albumin driven by pH changes: a molecular dynamics study. J. Phys. Chem. B 118, 921\u2013930 (2014).","journal-title":"J. Phys. Chem. B"},{"key":"637_CR70","doi-asserted-by":"publisher","DOI":"10.1002\/bip.23256","volume":"110","author":"CJ Jimenez","year":"2019","unstructured":"Jimenez, C. J. et al. Peptoids advance multidisciplinary research and undergraduate education in parallel: Sequence effects on conformation and lipid interactions. Biopolymers 110, e23256 (2019).","journal-title":"Biopolymers"},{"key":"637_CR71","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1021\/acsinfecdis.1c00536","volume":"8","author":"JE Nielsen","year":"2022","unstructured":"Nielsen, J. E. et al. Self-Assembly of Antimicrobial Peptoids Impacts Their Biological Effects on ESKAPE Bacterial Pathogens. ACS Infect. Dis. 8, 533\u2013545 (2022).","journal-title":"ACS Infect. Dis."},{"key":"637_CR72","doi-asserted-by":"publisher","unstructured":"Armbruster, C. R. et al. Staphylococcus aureus Protein A Mediates Interspecies Interactions at the Cell Surface of Pseudomonas aeruginosa. mBio 7, https:\/\/doi.org\/10.1128\/mBio.00538-16 (2016)","DOI":"10.1128\/mBio.00538-16"},{"key":"637_CR73","doi-asserted-by":"publisher","first-page":"e0174654","DOI":"10.1371\/journal.pone.0174654","volume":"12","author":"P Jorge","year":"2017","unstructured":"Jorge, P., Grzywacz, D., Kamysz, W., Lourenco, A. & Pereira, M. O. Searching for new strategies against biofilm infections: colistin-AMP combinations against Pseudomonas aeruginosa and Staphylococcus aureus single- and double-species biofilms. PLoS One 12, e0174654 (2017).","journal-title":"PLoS One"},{"key":"637_CR74","doi-asserted-by":"publisher","first-page":"e0135198","DOI":"10.1371\/journal.pone.0135198","volume":"10","author":"Z Yu","year":"2015","unstructured":"Yu, Z., Cai, Y., Qin, W., Lin, J. & Qiu, J. Polymyxin E Induces rapid Paenibacillus polymyxa death by damaging cell membrane while Ca2+ can protect cells from damage. PLoS One 10, e0135198 (2015).","journal-title":"PLoS One"},{"key":"637_CR75","doi-asserted-by":"publisher","unstructured":"Shah, R., Jankiewicz, O., Johnson, C., Livingston, B. & Dahl, J. U. Pseudomonas aeruginosa kills Staphylococcus aureus in a polyphosphate-dependent manner. bioRxiv. https:\/\/doi.org\/10.1101\/2023.12.05.570291 (2023)","DOI":"10.1101\/2023.12.05.570291"},{"key":"637_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-49302-y","volume":"13","author":"N Klubthawee","year":"2023","unstructured":"Klubthawee, N., Wongchai, M. & Aunpad, R. The bactericidal and antibiofilm effects of a lysine-substituted hybrid peptide, CM-10K14K, on biofilm-forming Staphylococcus epidermidis. Sci. Rep. 13, 22262 (2023).","journal-title":"Sci. Rep."},{"key":"637_CR77","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s00253-024-13134-1","volume":"108","author":"T Polat","year":"2024","unstructured":"Polat, T. et al. New-generation biofilm effective antimicrobial peptides and a real-time anti-biofilm activity assay: CoMIC. Appl. Microbiol. Biotechnol. 108, 316 (2024).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"637_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.575882","volume":"11","author":"A Salzer","year":"2020","unstructured":"Salzer, A., Keinhorster, D., Kastle, C., Kastle, B. & Wolz, C. Small Alarmone Synthetases RelP and RelQ of Staphylococcus aureus are involved in biofilm formation and maintenance under cell wall stress conditions. Front. Microbiol. 11, 575882 (2020).","journal-title":"Front. Microbiol."},{"key":"637_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-023-03381-5","volume":"23","author":"B Chen","year":"2023","unstructured":"Chen, B., Liu, H., Wang, Z., Ma, J. & Shen, Y. Effects of DJK-5 and chlorhexidine on exopolysaccharide volume and pH in oral biofilms. BMC Oral. Health 23, 705 (2023).","journal-title":"BMC Oral. Health"},{"key":"637_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.622534","volume":"11","author":"H Li","year":"2020","unstructured":"Li, H. et al. Reactive oxygen species in pathogen clearance: the killing mechanisms, the adaption response, and the side effects. Front. Microbiol. 11, 622534 (2020).","journal-title":"Front. Microbiol."},{"key":"637_CR81","doi-asserted-by":"publisher","unstructured":"Pletzer, D., Mansour, S. C., Wuerth, K., Rahanjam, N. & Hancock, R. E. New mouse model for chronic infections by gram-negative bacteria enabling the study of anti-infective efficacy and host-microbe interactions. mBio 8, https:\/\/doi.org\/10.1128\/mBio.00140-17 (2017)","DOI":"10.1128\/mBio.00140-17"},{"key":"637_CR82","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0140-6736(96)05169-0","volume":"348","author":"K Cheng","year":"1996","unstructured":"Cheng, K. et al. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 348, 639\u2013642 (1996).","journal-title":"Lancet"},{"key":"637_CR83","first-page":"88","volume":"52","author":"Centers for Disease C, P.","year":"2003","unstructured":"Centers for Disease C, P. Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections--Los Angeles County, California, 2002-2003. MMWR Morb. Mortal. Wkly Rep. 52, 88 (2003).","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"637_CR84","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nprot.2007.521","volume":"3","author":"I Wiegand","year":"2008","unstructured":"Wiegand, I., Hilpert, K. & Hancock, R. E. W. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat. Protoc. 3, 163\u2013175 (2008).","journal-title":"Nat. Protoc."},{"key":"637_CR85","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 11th edn (Clinical and Laboratory Standards Institute, 2018)."},{"key":"637_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkg301","volume":"52","author":"FC Odds","year":"2003","unstructured":"Odds, F. C. Synergy, antagonism, and what the chequerboard puts between them. J. Antimicrob. Chemother. 52, 1 (2003).","journal-title":"J. Antimicrob. Chemother."},{"key":"637_CR87","doi-asserted-by":"publisher","first-page":"6859","DOI":"10.1128\/AEM.02370-16","volume":"82","author":"CN Krute","year":"2016","unstructured":"Krute, C. N. et al. Generation of a stable plasmid for in vitro and in vivo studies of staphylococcus species. Appl Environ. Microbiol. 82, 6859\u20136869 (2016).","journal-title":"Appl Environ. Microbiol."},{"key":"637_CR88","first-page":"000193","volume":"3","author":"IR Monk","year":"2021","unstructured":"Monk, I. R. & Stinear, T. P. From cloning to mutant in 5 days: rapid allelic exchange in Staphylococcus aureus. Access Microbiol. 3, 000193 (2021).","journal-title":"Access Microbiol."},{"key":"637_CR89","unstructured":"Miller, J. H. Experiments in molecular genetics. (Cold Spring Harbor Laboratory, 1972)."},{"key":"637_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-023-00401-8","volume":"9","author":"RG Maset","year":"2023","unstructured":"Maset, R. G. et al. Combining SNAPs with antibiotics shows enhanced synergistic efficacy against S. aureus and P. aeruginosa biofilms. NPJ Biofilms Microbiomes 9, 36 (2023).","journal-title":"NPJ Biofilms Microbiomes"}],"container-title":["npj Biofilms and Microbiomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41522-024-00637-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-024-00637-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-024-00637-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T11:05:51Z","timestamp":1736334351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41522-024-00637-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["637"],"URL":"https:\/\/doi.org\/10.1038\/s41522-024-00637-y","relation":{},"ISSN":["2055-5008"],"issn-type":[{"value":"2055-5008","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,8]]},"assertion":[{"value":"7 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The DJK-5 peptide described here has been filed for patent protection by REWH and co-inventors, assigned to REWH\u2019s employer, the University of British Columbia, and licenced to ABT Innovations Inc., Victoria, Canada, in which the University of British Columbia, REWH and JO own shares.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}